Here, NSD-Loss tumours are significantly more likely to undergo ecDNA amplification at the MDM2 locus than SD tumours (Methods, Table S13, risk ratio = 5.83, FDR = 0.029). This evidence concerns the gene MDM2 and neoplasm.